Bharat Biotech, GSK to halve price of malaria vaccine by 2028
Drugmakers
Bharat Biotech
and
GSK
will cut the price of their
malaria vaccine
to $5 per dose by 2028, more than halving its current cost, they said on Wednesday.
The vaccine,
Mosquirix
or RTS,S, was developed by
GSK
and the non-profit PATH, and was the first
malaria
vaccine to get approval from the World Health Organization in 2022.
GSK is working on a technology transfer to Bharat, and will continue to supply the adjuvant part of the vaccine to Bharat when the Indian drugmaker fully takes over production of the shot by 2028.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Villa For Sale in Dubai Might Surprise You
Villas in Dubai | Search ads
Learn More
Undo
A phased reduction in price for the vaccine will begin immediately, GSK said in a statement with Bharat, reaching the target price of $5 by 2028.
The price cut was "driven by process improvements, expanded production capacity, cost-effective manufacturing, and minimal profit margins," the statement read.
Live Events
Malaria kills more than 500,000 people annually, mainly children aged five and under in sub-Saharan Africa, according to WHO estimates. Cases and deaths fell significantly between 2000 and 2015, but progress has since stalled and even reversed, with a particular jump in mortality during the COVID-19 pandemic.
Many experts have expressed hope that vaccines can help turn the tide in the fight against the mosquito-borne disease. But price has been an issue, particularly when compared to other tools to prevent malaria like bed nets.
GSK has previously said it was committed to supplying up to 18 million vaccine doses between 2023 and the end of this year. The company plans to supply 15 million doses annually from 2026-2028, according to a spokesperson.
Wednesday's announcement comes as
Gavi
- a global vaccine group that helps buy childhood vaccines in the world's poorest countries - holds an event in Brussels to raise funding for its work over the next five years, as governments pull back from international aid.
GSK and Bharat said the price reduction showed their commitment to Gavi, which has been funding some of the roll-out of the malaria vaccine. Twelve African countries are set to introduce the vaccine in their routine immunisation programmes by the end of this year with Gavi's support.
The other approved malaria vaccine, developed by the University of Oxford and the Serum Institute of India, is priced at under $4 a dose.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
United News of India
16 minutes ago
- United News of India
Covid cases in Maha dip
Mumbai, June 25 (UNI) The number of Covid cases in Maharashtra has started slowing down since its peak in May and early this month, as 25 new patients have been found in the state in last 24 hours. A total of 2,395 Covid patients have been found and 33 deaths have been recorded in the state since this year. The state Health officials said today that the number of Covid patients in the state was increasing in May and early June. Due to this, the daily number of patients in the state had reached 100 between June 11 and 13. After that, the number of patients decreased by almost half from June 14. Since then, the rate of increase in corona infection has been low. Of 25 new Covid patients detected in the state in last 24 hours, Mumbai-8, Nagpur-5, Chandrapur-3, Chhatrapati Sambhajinagar-2 and Pune city, Pune Rural, Thane, Navi Mumbai, Bhiwandi, Kolhapur and Akola-1 patient each. Out of 2,395 patients diagnosed with Covid in the state, the maximum number of 965 patients has been registered in Mumbai. The number of active patients in the state is 256, and 2,106 patients have recovered. Since January, 33 patients have died in the state, out of which 32 patients were suffering from co-morbidities, sources added. UNI SP SS
Time of India
24 minutes ago
- Time of India
Maharashtra reports 30 new COVID-19 cases, three deaths
Maharashtra recorded 30 cases of COVID-19 on Wednesday and three deaths, including one in Satara and two in Nagpur, the state health department said. Since January 1, the state has logged 2,425 cases of the infection and 36 fatalities caused by coronavirus, said officials. Of the new cases, eight are from Mumbai, three from the jurisdiction of the Thane Municipal Corporation , two each from areas under the civic bodies of Navi Mumbai and Kalyan-Dombivali, eight from Pune, five from Nagpur and one each from Kolhapur and Sangli, said an official statement. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now Undo It said that 35 of the 36 persons who succumbed to the viral infection since the beginning of this year had comorbidities (medical conditions that coexist alongside a primary diagnosis). The department has conducted 27,394 COVID-19 tests across the state so far this year, while 2,166 patients have recovered to date, the statement said. Live Events Meanwhile, Mumbai has reported 973 cases, including 532 in June, since January 1.
Time of India
33 minutes ago
- Time of India
No Family Doctors, No Continuity of Care: Dr. Paul Flags Dangerous Gap in India's Healthcare System
New Delhi: In a bold call for transformation, Dr. V. K. Paul , Member (Health), NITI Aayog , outlined a sweeping blueprint to revamp India's medical education system, stating that the country must train not just for adequacy but for ambition, as part of its journey toward becoming a developed nation. Speaking at a policy dialogue hosted by the Centre for Social and Economic Progress (CSEP), Dr. Paul addressed critical issues of medical manpower, quality of postgraduate training, and structural reforms needed to match the healthcare needs of 2040 and beyond. 'We must shed the illusion that we're anywhere close to sufficient,' Dr. Paul said. 'A ratio of one doctor per 1,000, the WHO norm, may suffice for low-income nations. For India, aiming to be a global leader, we need three per 1,000—this must be our goalpost by 2040.' India's Specialist Shortage is 'Alarming' Citing data on specialist shortfalls, Dr. Paul painted a sobering picture stating that the current rate of producing 5,500 general surgeons per year, India will take 34 years to match the average for lower-middle-income countries and 69 years to meet high-income benchmarks. For psychiatrists, the country has 0.7 per 100,000 people, compared to the LMIC average of 2, and would require 23 years to close the gap. For cardiologists, India lags drastically—with projections of an 82-year wait to meet international standards. 'This is not just a workforce issue; it's an issue of national health resilience,' he said. Dr. Paul called for an overhaul of the MBBS curriculum to better prepare graduates for real-world care. He stressed the need for deeper exposure to internal medicine, geriatrics, psychiatry, and chronic disease management—areas that often receive less than four weeks of training under the current system. 'Our internship structure is broken. How can a student become proficient in schizophrenia or diabetes management with three weeks of exposure?' he asked. 'In high-income countries, becoming a family physician takes 10 years. We try to compress all that into five and a half.' Urgent Need to Mainstream Family and Emergency Medicine Perhaps the most impassioned part of Dr. Paul's address was his plea to mainstream Family Medicine—a specialty largely ignored in Indian medical training. 'If we continue on our current path, by 2035 we will be a country with only specialists and barely any generalists,' he warned. 'That's a broken healthcare model. Family physicians are critical for managing chronic diseases, elderly care, mental health, and ensuring continuity of care.' Despite national policy backing and global best practices, India has less than 100 Family Medicine postgraduate seats. Dr. Paul urged the National Medical Commission (NMC) to urgently expand these, including adopting the All India Institute of Medical Sciences (AIIMS) model, where Family Medicine training is delivered without needing a standalone department. He also highlighted the neglect of Emergency Medicine, which he called 'the face of healthcare' and critical for equitable access. 'Emergency departments in most medical colleges are grossly underdeveloped. A single resident, 30 patients, and no consultant oversight—that's the reality today,' he said, advocating mandatory emergency medicine departments in new colleges. Dr. Paul urged policymakers to view health not as a cost but as a driver of economic development. 'Healthy people drive innovation, productivity, and growth. The healthcare workforce must be seen as a core part of India's human capital strategy,' he said. He concluded with a call for collaboration across ministries, private sector participation, and a shift in mindset: ' Medical education reform is no longer optional. It is foundational to India's ambition to become a developed, equitable nation.'
